Chief, Goutham Narla, MD, PhD
Goutham Narla, MD, PhD earned his BS in Biology and Economics from Santa Clara University in California and his MD and PhD from Mount Sinai School of Medicine in New York. He also completed his residency in Internal Medicine and fellowship in Medical Genetics at Mount Sinai. After finishing his fellowship, he moved to Ohio in 2012 to work at Case Western Reserve University (CWRU), where he later become an Associate Professor with tenure. In July 2018, he joined the faculty at Michigan Medicine to become the seventh Chief of the Division of Genetic Medicine since the division’s inception in 1977.
Dr. Narla has held several leadership positions, particularly focusing on education and training, both at Mount Sinai and CWRU. At Mount Sinai, he served as the Director of the Physician-Scientist Training Residency Program, Assistant Program Director of the Medical Scientist Training Program (MSTP), and was a member of the Medical School Admissions Committee. At CWRU, Dr. Narla sat on the MSTP Steering Committee and the Pharmacology Steering Committee. In 2012, he was named the first Harrington Distinguished Scholar (Early Career Award). He is currently the President of The Young Scientist Foundation, and a member of the American Association for Cancer Research and the American Society for Clinical Investigation.
While in medical school, Dr. Narla trained in Dr. Scott Friedman’s laboratory at Mount Sinai, where he first discovered the KLF6 gene and its ability to suppress cancerous tumors. His current research focuses on the identification and characterization of the key negative regulators, tumor suppressor proteins of cancer development and progression, and the development of small molecule-based therapies that activate tumor suppressor genes for the treatment of cancer. To date, Dr. Narla has authored 11 patents. He has over 65 publications in journals including Nature Genetics, Science, Science Translational Medicine, Proceedings of the National Academy of Sciences, and the Journal of Clinical Investigation. Dr. Narla's clinical interest is focused on the care of high risk cancer patients and their family members.
Jeffrey W. Innis, MD, PhD
Morton S. and Henrietta K. Sellner Professor of Human Genetics
Professor, Department of Human Genetics
Professor, Department of Internal Medicine
Professor, Department of Pediatrics and Communicable Diseases
Service Chief, Adult Medical Gentetics Clinic
Elena M. Stoffel, MD, MPH
Assistant Professor, Department of Internal Medicine
Lead, Clinical Cancer Genetics
Dorothy Schroeder, MSA
Phone: (734) 764-9516
Jeff Kolodica, BA
Financial Senior Manager
Phone: (734) 998-4999
Billie Norman, MBA, PHR, SHRM-CP
Phone: (734) 232-4594
Administrative Manager/Clinical Liaison
Phone: (734) 764-8100